March 1-2: Introduction to Health Technology Assessment- Virtual
9:00AM–11:00AM Eastern Standard Time (EST)
14:00–16:00 Coordinated Universal Time (UTC)
15:00–17:00 Central European Time (CET)
Wednesday, 2 March 2022 | Course runs 2 consecutive days
9:00AM–11:00AM Eastern Standard Time (EST)
14:00–16:00 Coordinated Universal Time (UTC)
15:00–17:00 Central European Time (CET)
DESCRIPTION
Uwe Siebert, MD, MPH, MSc, ScD
Professor & Chair
UMIT - University for Health Sciences
Medical Informatics and Technology
Innsbruck, Austria and
Harvard Chan School of Public Health
Harvard University
Boston, MA, USA
Petra Schnell-Inderst, MPH, PhD, Dipl. Biol
Senior Scientist
UMIT - University for Health Sciences
Medical Informatics and Technology
Innsbruck, Austria
March 1, 2022 - March 2, 2022
Back to all short courses
Introduction to Health Technology Assessment (Virtual)
LEVEL: Introductory
TRACK: Health Technology Assessment
LENGTH: 4 Hours | Course runs 2 consecutive days, 2 hours each day
Register Now
9:00AM–11:00AM Eastern Standard Time (EST)
14:00–16:00 Coordinated Universal Time (UTC)
15:00–17:00 Central European Time (CET)
Wednesday, 2 March 2022 | Course runs 2 consecutive days
9:00AM–11:00AM Eastern Standard Time (EST)
14:00–16:00 Coordinated Universal Time (UTC)
15:00–17:00 Central European Time (CET)
Click for time zone conversion
DESCRIPTION
This introductory course is designed to teach academic researchers, health policy decision makers, manufacturers, and clinicians about the key elements, methods, and language of health technology assessment (HTA). The course provides an overview of basic HTA principles including benefit assessment (biostatistics, clinical epidemiology, patient-relevant outcomes, risk-benefit assessment), economic evaluation (costing, cost-effectiveness analysis, pharmacoeconomic modeling, budget impact analysis, resource allocation), and ELSI (ethical, legal, and social implications). Using real world examples covering both drugs and devices, the course will review the practical steps involved in developing and using HTA reports in different countries and health care systems. Group discussion will focus on the perspectives of different stakeholders and the implementation of HTA in health care decision making. This course is suitable for those with little or no experience with HTA.
FACULTY MEMBERS
Uwe Siebert, MD, MPH, MSc, ScD
Professor & Chair
UMIT - University for Health Sciences
Medical Informatics and Technology
Innsbruck, Austria and
Harvard Chan School of Public Health
Harvard University
Boston, MA, USA
Petra Schnell-Inderst, MPH, PhD, Dipl. Biol
Senior Scientist
UMIT - University for Health Sciences
Medical Informatics and Technology
Innsbruck, Austria
Basic Schedule:
Class Time: 2 hours daily